WESTFORD, Mass., Feb. 6, 2012 /PRNewswire/ -- Cynosure, Inc.
(NASDAQ: CYNO), a leader in laser- and light-based treatments for
minimally invasive and non-invasive aesthetic applications, today
announced that President and Chief Executive Officer Michael Davin and Executive Vice President,
Treasurer and Chief Financial Officer Timothy Baker will present at two upcoming
investor conferences.
On Wednesday, February 15 at
4:00 p.m. (ET), management will
give a brief presentation followed by a fireside chat at the
Leerink Swann 2012 Global Healthcare Conference in New York City.
On Tuesday, February 28 at
8:30 a.m. (ET), management will
present at the Citi 2012 Global Healthcare Conference in
New York City.
To access the live or archived webcasts of these events, visit
the "Investor Relations" portion of Cynosure's website,
www.cynosure.com.
About Cynosure, Inc.
Cynosure, Inc. develops and markets aesthetic treatment
systems that are used by physicians and other practitioners to
perform non-invasive and minimally invasive procedures to remove
hair, treat vascular and pigmented lesions, rejuvenate the skin,
liquefy and remove unwanted fat through laser lipolysis, reduce the
appearance of cellulite and treat Onychomycosis. Cynosure's
products include a broad range of laser and other light-based
energy sources, including Alexandrite, pulse dye, Q-switched,
Nd:YAG and diode lasers, as well as intense pulsed light. Cynosure
was founded in 1991. For corporate or product information, contact
Cynosure at 800-886-2966, or visit www.cynosure.com.
Contact:
Scott Solomon
Vice President
Sharon Merrill Associates, Inc.
617.542.5300
cyno@investorrelations.com
SOURCE Cynosure, Inc.